We’re up to 13: Retractions keep coming for Diederik Stapel

The retraction count is up to 13 for Dutch psychology fraudster Diederik Stapel, with four more in the publications the Journal of Consumer Research, Motivation & Emotion, Psychology & Marketing, and Social Cognition. Here are the notices:

Happy second anniversary, Retraction Watch: Plus, our plans for year three

We didn’t plan it this way, but our second anniversary gift came a few days early this week, when we learned that a retraction notice had cited us. Given that the traditional second anniversary gift is cotton, and we’re really not sure what to do with that information, we’re much happier — and humbled — … Continue reading Happy second anniversary, Retraction Watch: Plus, our plans for year three

Three more retractions for Diederik Stapel

We apologize for what must seem like a constant drip, drip, drip, but we have three more retractions from Diederik Stapel to report, all from the European Journal of Social Psychology. The first, in order of publication date, involves a 2006 paper by Stapel and co-author Camille Johnson — whose name has appeared on several … Continue reading Three more retractions for Diederik Stapel

Does anesthesiology have a problem? Final version of report suggests Fujii will take retraction record, with 172

Japanese investigators have concluded that Yoshitaka Fujii, an expert in postoperative nausea and vomiting whose findings drew scrutiny in 2000 but who continued to publish prolifically for a decade after, fabricated his results in at least 172 published studies. That number nearly doubles that of the current unofficial retraction record holder, Joachim Boldt. An inquiry … Continue reading Does anesthesiology have a problem? Final version of report suggests Fujii will take retraction record, with 172

Following investigation, Erasmus social psychology professor retracts two studies, resigns

The social psychology community, already rocked last year by the Diederik Stapel scandal, now has another set of allegations to dissect. Dirk Smeesters, a professor of consumer behavior and society at the Rotterdam School of Management, part of Erasmus University, has resigned amid serious questions about his work. According to an Erasmus press release, a … Continue reading Following investigation, Erasmus social psychology professor retracts two studies, resigns

Is misconduct more likely in drug trials than in other biomedical research?

A new paper by Chicago pharmacy researchers suggests that researchers performing drug studies are more likely to commit fraud than are their colleagues in the rest of biomedicine. In the paper, “Retraction Publications in the Drug Literature,” which appears in Pharmacotherapy, Jennifer C. Samp, Glen T. Schumock, and A. Simon Pickard take a look at … Continue reading Is misconduct more likely in drug trials than in other biomedical research?

Second retraction for former SUNY Upstate department chair found guilty of misconduct

Last week, we covered the case of Michael W. Miller, a former department chair at the State University of New York (SUNY) Upstate who was forced to retract a paper in the Journal of Neurochemistry after a university investigation found he had committed misconduct. We figured more retractions might be on the way, so we … Continue reading Second retraction for former SUNY Upstate department chair found guilty of misconduct

University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

Stefano Fiorucci, a gastroenterology researcher at the University of Perugia in Italy, has been indicted for fraud and embezzlement, after a university investigation found that he had manipulated images in papers that he used to win about 2 million Euros in grant funding. The case, which has so far resulted in four retractions and nine … Continue reading University of Perugia researcher faces trial for embezzlement, fraud following 13 retractions and Expressions of Concern

So how peripheral was Dipak Das’ resveratrol work, really?

In the wake of the massive allegations of fraud by resveratrol researcher Dipak Das, other researchers in the field are clearly trying to distance themselves from the University of Connecticut scientist. Nir Barzilai told us yesterday, for example, that despite Das seemingly’ impressive publication record, “Rome was not built on Dr. Das.” Harvard’s David Sinclair went … Continue reading So how peripheral was Dipak Das’ resveratrol work, really?

The Year of the Retraction: A look back at 2011

If Retraction Watch was actually a business, as opposed — for the moment, anyway — to a labor of love for two guys with day jobs, 2011 would have been a very good year for business. It was a year that will probably see close to 400 retractions, including a number of high-profile ones, once … Continue reading The Year of the Retraction: A look back at 2011